等待开盘 02-04 09:30:00 美东时间
+0.040
+0.16%
Pelthos Therapeutics secured $30 million in financing from Horizon Technology Finance, with up to an additional $20 million for future growth. Funds will support the commercialization of its lead product ZELSUVMI™, recently acquired FDA-approved infectious disease products, and general corporate purposes. The facility is minimally dilutive to existing shareholders, with proceeds aimed at enhancing Pelthos' product portfolio and market reach.
01-13 13:30
Horizon Technology Finance (NASDAQ:HRZN) declared $0.11/share monthly dividend, in line with previous. Payable Jan. 15; for shareholders of record Dec. 17; ex-div Dec. 17. Payable Feb. 13; for shareho...
2025-10-29 05:21
Horizon Technology ( ($HRZN) ) just unveiled an announcement. On August 7, 2025...
2025-08-08 06:19
- HRZN Originates $59.7 Million of New Loans in Q2 -- HRZN Ends Quarter with Committed Backlog of $149.0 Million -Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe
2025-07-10 04:18
Specialty finance company Horizon Technology Finance (NASDAQ:HRZN) announced on Monday the appointment of Paul Seitz as chief investment officer. Daniel Devorsetz has stepped down as COO and chief inv...
2025-06-10 19:32
An announcement from Horizon Technology ( ($HRZN) ) is now available. On June 5...
2025-06-10 05:52
Horizon Technology ( ($HRZN) ) has issued an update. On May 23, 2025, Horizon F...
2025-05-28 04:51
Horizon Technology ( ($HRZN) ) has provided an update. On May 15, 2025, Horizon...
2025-05-16 04:55
An announcement from Horizon Technology ( ($HRZN) ) is now available. On March ...
2025-04-01 04:33
Horizon Technology Finance (HRZN) has disclosed a new risk, in the Debt & F...
2025-03-06 14:03